EXUMA Biotech, Corp., a clinical-stage biotechnology company discovering and developing cell and gene immunotherapies for solid and hematological malignancies, is presenting clinical data from a ...

Tevogen.AI, in collaboration with Microsoft domain experts, will create new algorithms to decode the interactions between ...

Caregiving can take many forms, often requiring a profound shift in daily life. While navigating a disease is an immense challenge for patients, managing the emotional, logistical and personal burdens ...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, Jan. 23, ...

A new review led by researchers at Moffitt Cancer Center assessed how three genomic tests — Decipher, Oncotype DX Genomic ...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, Jan. 24, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) ...

The biotech sector in 2025 presents a landscape brimming with both opportunities and challenges. The industry is being shaped ...

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.

As the percentage of the global population over 65 continues to increase, the popularity of anti-aging stocks is rising in ...

Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to ...

CAR T-cell therapies have established themselves as a frequently very successful and overall promising treatment option for ...